First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults
Clinical trial NCT06194318 · COMPLETED
Trial details
- NCT number
- NCT06194318
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2025-02-26
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.